Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer
- Resource Type
- Article
- Source
- In
Clinical Breast Cancer April 2017 17(2):91-99 - Subject
- Language
- ISSN
- 1526-8209